Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis

Atherosclerosis

Volumn 162, Issue 1, 2002, Pages 187-191

  Wieland, Eberhard ^a   Schettler, Volker ^a   Armstrong, Victor William ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

C reactive protein; Coronary heart disease; Extracorporeal circulation; Hypercholesterolemia; Inflammation

Indexed keywords

BUFFER; C REACTIVE PROTEIN; HEPARIN; LOW DENSITY LIPOPROTEIN;

ADULT; APHERESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MALE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TREATMENT OUTCOME; WESTERN BLOTTING; WESTERN EUROPE;

ADULT; AGED; ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; C-REACTIVE PROTEIN; COMBINED MODALITY THERAPY; CORONARY DISEASE; FEMALE; HEPARIN; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBSERVER VARIATION; PRECIPITATION; TREATMENT OUTCOME;

EID: 0036230026     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00698-0     Document Type: Article

References (33)

1. Atherosclerosis - An inflammatory disease
2. Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men
3. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
4. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
5. Complement activation by C-reactive protein complexes
6. C-reactive protein and complement are important mediators of tissue injury in acute myocardial infarction
7. Immunohistochemical demonstration of enzymatically modified LDL and its colocalization with the terminal complement complex in early atherosclerotic lesion
8. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
9. C-reactive protein in the arterial intima. Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
10. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherogenesis
11. Direct proinflammatory effect of C-reactive protein on human endothelial cells
12. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease
13. Long-term effects of pravastatin on plasma concentration of C-reactive protein
14. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia
15. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP system
16. The HELP system: Clinical experience of 10 years: A report
17. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications
18. Quantitative determination of high-, low-, and very-low density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining
19. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
20. A simple specific method for precipitation of low density lipoproteins
21. Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): Kinetic analysis of the post-treatment return to baseline levels
22. Cholesterol lowering in atherosclerosis
23. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
24. Beyond cholesterol, modifications of low-density lipoprotein that increase its atherogenicity
25. The role of oxidized lipoproteins in atherogenesis
26. Complement activation by oxidatively modified low density lipoproteins
27. On the pathogenesis of atherosclerosis: Enzymatic transformation of human low density lipoprotein to an atherogenic moiety
28. Complement and atherogenesis: Binding of CRP to degraded, non-oxidized LDL enhances complement activation
29. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
30. HELP apheresis in the treatment of sepsis
31. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
32. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults
33. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease